Brainsway (BWAY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BrainsWay reported a strong 26% revenue growth in Q3 2024, raising its full-year revenue guidance to $40-41 million and achieving net income of $0.7 million. The company plans to leverage a recent $20 million equity financing for strategic initiatives and market expansion. BrainsWay continues to advance its Deep TMS technology, with increased system deployments and ongoing clinical trials, enhancing its leadership in mental health treatment innovations.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
